This announcement is a separate document:
ST天圣:监事会对董事会关于2023年度保留意见审计报告涉及事项的专项说明的意见
Tiansheng Pharmaceutical Group: Opinions of the Board of Supervisors on the Board's Special Instructions on Matters Involved in the 2023 Qualified Opinion Audit Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.